A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)	cGvHD	Enrolling by invitation	Phase 2	2024-08-12		NCT06186804

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abbisko Therapeutics Co, Ltd	22

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fujian Medical University Union Hospital	Fuzhou	China	38
Guangdong Provincial Peoplep's Hospital	Guangzhou	China	1
Hematology Hospital of Chinese Academy of Medical Sciences	Tianjin	China	2
Peking University People's Hospital	Beijing	China	44
The Fir St Affiliated Hospital,Zhejiang Univer Sity School of Medicine	Hangzhou	China	1
The First Affiliated Hospital of Nanchang University	Nanchang	China	77
The first affiliated hospital of suzhou university	Suzhou	China	2
The First Hospital of Jilin University	Changchun	China	46
The First Teaching Hospital of Xinjiang Medical University	Xinjiang	China	1
The Second Affiliated Hospital of the Army Medical University	Chongqing	China	1
Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology	Wuhan	China	1
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology	Wuhan	China	3
West China Hospital of Sichuan University	Chengdu	China	68
Zhujiang Hospital of Southern Medical University	Zhujiang	China	2